MCLEAN, Va., Dec. 01, 2016 -- Gladstone Commercial Corporation (NASDAQ:GOOD) ("Gladstone Commercial"), a real estate investment trust focused on acquiring, owning and operating net leased office and industrial properties, announced today that it completed the disposition of two properties for gross proceeds of $3.9 million. The dispositions bring the company’s LTM sales of non-core assets to $14.0 million.
One property, located in Toledo, OH, sold for gross proceeds of $3.2 million. The sale included a 23,368 square foot medical office facility leased to Mercy Health with approximately 4 years of remaining lease term. The company recognized a levered IRR of 11% on its investment.
The second property, located in Montgomery, AL, sold for gross proceeds of approximately $700,000. The sale included a 29,472 square foot industrial facility leased to Cummins, Inc., a global fuel engine design, manufacturing and servicing company with a remaining lease term of approximately 10 months. The company recognized a levered IRR of 12% on its investment.
"These transactions are consistent with our capital recycling operating strategy that seeks to divest non-core assets while maintaining a best-in-class portfolio in strong secondary markets," said Brandon Flickinger, Director of Operations (Real Estate) of Gladstone Commercial.
About Gladstone Commercial Corporation (NASDAQ:GOOD):
Gladstone Commercial is a real estate investment trust focused on acquiring, owning and operating net leased industrial and office properties across the United States. Gladstone Commercial’s real estate portfolio consists of 95 properties located in 24 states, totaling approximately 11.0 million square feet. For additional information please visit www.gladstonecommercial.com.
For Broker Submittals:
| South/Southwest: | Tennessee/Kentucky: |
| Buzz Cooper | Brandon Flickinger |
| Senior Managing Director | Director, Real Estate |
| (703) 287-5815 | (703) 287-5819 |
| [email protected] | [email protected] |
| West: | Midwest/Northeast: |
| Andrew White | Matt Tucker |
| Managing Director | Managing Director |
| (310) 953-4960 | (703) 287-5830 |
| [email protected] | [email protected] |


FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Anta Sports Expands Global Footprint With Strategic Puma Stake
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 



